5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

Laurent P LacroixChristian A Heidbreder


The present study investigated the neurochemical effects of the selective 5-HT(6) receptor antagonist SB-271046 in the rat medial prefrontal cortex (mPFC). The effect of SB-271046 on extracellular levels of dopamine (DA), norepinephrine (NE), and serotonin (5-HT) in the mPFC was examined using in vivo microdialysis in the freely moving rat. SB-271046 (10 mg/kg, p.o.) produced a significant increase in extracellular levels of both DA and NE without altering 5-HT neurotransmission. These results further support the rationale for the use of 5-HT(6) receptor antagonists in the treatment of cognitive dysfunction associated with psychiatric diseases.


Apr 23, 2005·Psychopharmacology·Paula D HatcherDeclan N C Jones
Nov 15, 2011·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Robert A ComleySylvain Houle
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Neil UptonDavid J Virley
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cindy K J LiebenRudy Schreiber
Jul 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B FlorescoMaric T L Tse
Dec 21, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Joshua S RodeferJørn Arnt
Nov 10, 2015·Expert Opinion on Investigational Drugs·Karsten WickeAnton Bespalov
Nov 19, 2015·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Alvin V TerryScott J Webster
Feb 19, 2011·Current Opinion in Pharmacology·Xabier CodonyMaria Javier Ramírez
Dec 28, 2010·Neuropharmacology·V ValentiniG Di Chiara
Feb 17, 2010·Neuropharmacology·Paul T FrancisMitchell K Lai
Sep 8, 2009·Neurobiology of Learning and Memory·A Huerta-RivasA Meneses
Feb 1, 2008·European Journal of Pharmacology·Anna Wesołowska, Agnieszka Nikiforuk
Dec 7, 2007·Bioorganic & Medicinal Chemistry Letters·Churl Min SeongNo Sang Park
Jul 13, 2007·Bioorganic & Medicinal Chemistry·Hassan ElokdahLee E Schechter
Mar 27, 2007·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pia WeikopJan Kehr
Mar 26, 2016·Progress in Neurobiology·Philippe De Deurwaerdère, Giuseppe Di Giovanni
Oct 20, 2006·Pharmacology & Therapeutics·K D Alex, E A Pehek
Sep 23, 2006·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rudy SchreiberArjan Blokland
Aug 30, 2005·Bioorganic & Medicinal Chemistry Letters·Derek C ColeLee E Schechter


Feb 22, 1991·Science·T Sawaguchi, P S Goldman-Rakic
Aug 17, 1995·Nature·G V Williams, P S Goldman-Rakic
May 1, 1995·Pharmacology & Therapeutics·P R Saxena
May 28, 1993·Biochemical and Biophysical Research Communications·M RuatJ C Schwartz
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·B L MurphyR H Roth
Jan 1, 1997·Journal of Psychopharmacology·A F Arnsten
Nov 14, 1997·Journal of Neurophysiology·M WatanabeK Hikosaka
Jul 31, 1999·Schizophrenia Research·J A Frederick, J H Meador-Woodruff
Mar 10, 2000·Brain Research·P Izurieta-SánchezY Michotte
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·T A Branchek, T P Blackburn
Aug 6, 2000·British Journal of Pharmacology·C RoutledgeD N Middlemiss
Oct 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lee A DawsonP Li
Nov 10, 2001·Psychopharmacology·Derek C Rogers, Jim J Hagan
Feb 19, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Junji IchikawaHerbert Y Meltzer
Mar 13, 2002·Pharmacology, Biochemistry, and Behavior·B PouzetJørn Arnt

Related Concepts

Serotonin 6 receptor
Prefrontal Cortex
Serotonin Measurement
Antagonist Muscle Action
Extracellular Space
Congenital Abnormal Synostosis
Receptors, Tryptamine

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.